SCHEMBL6699077

SCHEMBL6699077

CNC1CCN(CCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
CCR5 P51681 5/20 0.51
KCNA3 P22001 1/20 0.49
SCN5A Q14524 1/20 0.48
FAAH O00519 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
TSHR P16473 1/20 0.45
ALOX12 P18054 1/20 0.45
MAPK1 P28482 1/20 0.45
MTOR P42345 1/20 0.45
RAB9A P51151 1/20 0.45
CACNA1B Q00975 1/20 0.45
BLM P54132 1/20 0.44
PMP22 Q01453 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CARM1 Q86X55 1/20 0.44
PRMT6 Q96LA8 1/20 0.44
CACNA1F O60840 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10362349 0.92 SCN5A (0.55) MEN1KMT2ASCN5AFAAHCYP3A4
SCHEMBL3639939 0.87 KCNA3 (0.65) CCR5KCNA3CYP2D6OPRM1SIGMAR1
Hydrochloric Acid SCHEMBL6698846 0.85 KCNA3 (0.63) CCR5KCNA3CYP2D6OPRM1SIGMAR1
SCHEMBL27763800 0.78 HTR2A (0.56) CARM1PRMT6HTR2AHTR2CHTR7
SCHEMBL6704673 0.77 CCR5 (0.56) CCR5KCNA3CACNA1BCACNA1FHTR1A
Hydrochloric Acid SCHEMBL29280917 0.77 HTR2A (0.55) CARM1PRMT6HTR2AHTR2CHTR7
SCHEMBL27570739 0.75
Hydrochloric Acid SCHEMBL27570794 0.74
SCHEMBL8151042 0.74 BCHE (0.62) CYP2D6DRD2DRD4HRH1DRD3
SCHEMBL7296899 0.74 SIGMAR1 (0.61) MEN1KMT2ACCR5SCN5AFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006081-A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity ASTRAZENECA AB (SE) 2004-01-08 US disclosed
EP-1289957-A1 PHARMACEUTICALLY ACTIVE PIPERIDINE DERIVATIVES, IN PARTICULAR AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY AstraZeneca AB (SE) 2003-03-12 EP disclosed
WO-2001087839-A1 PHARMACEUTICALLY ACTIVE PIPERIDINE DERIVATIVES, IN PARTICULAR AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY ASTRAZENECA AB (SE) 2001-11-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006081-A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity CCR5, CCR2, CCR1 MEN1 4785/4885KMT2A 4756/4885CCR5 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.